miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

A. Holleman; I. Chung; R.R. Olsen; B. Kwak; A. Mizokami; N. Saijo; A. Parissenti; Z. Duan; E.E. Voest; B.R. Zetter

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

A. Holleman, I. Chung, R.R. Olsen, B. Kwak, A. Mizokami, N. Saijo, A. Parissenti, Z. Duan, E.E. Voest, B.R. Zetter

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	4386-4398
Number of pages	13
Journal	Oncogene
Volume	30
Issue number	43
Publication status	Published - 2011

Cite this

@article{fd43097c1b4144129f490528a2a8bca4,

title = "miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.",

author = "A. Holleman and I. Chung and R.R. Olsen and B. Kwak and A. Mizokami and N. Saijo and A. Parissenti and Z. Duan and E.E. Voest and B.R. Zetter",

year = "2011",

language = "English",

volume = "30",

pages = "4386--4398",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "43",

}

TY - JOUR

T1 - miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

AU - Holleman, A.

AU - Chung, I.

AU - Olsen, R.R.

AU - Kwak, B.

AU - Mizokami, A.

AU - Saijo, N.

AU - Parissenti, A.

AU - Duan, Z.

AU - Voest, E.E.

AU - Zetter, B.R.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0950-9232

VL - 30

SP - 4386

EP - 4398

JO - Oncogene

JF - Oncogene

IS - 43

ER -